Related Experiment Video
Updated: May 5, 2026

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
Published on: October 13, 2023
Towards pathway curation through literature mining--a case study using PharmGKB
K E Ravikumar1, Kavishwar B Wagholikar, Hongfang Liu
1Department of Health Sciences Research, College of Medicine, Mayo clinic, Rochester, MN, 55905, USA. KomandurElayavilli.Ravikumar@mayo.edu.
Abstract:
The creation of biological pathway knowledge bases is largely driven by manual effort to curate based on evidences from the scientific literature. It is highly challenging for the curators to keep up with the literature. Text mining applications have been developed in the last decade to assist human curators to speed up the curation pace where majority of them aim to identify the most relevant papers for curation with little attempt to directly extract the pathway information from text. In this paper, we describe a rule-based literature mining system to extract pathway information from text. We evaluated the system using curated pharmacokinetic (PK) and pharmacodynamic (PD) pathways in PharmGKB. The system achieved an F-measure of 63.11% and 34.99% for entity extraction and event extraction respectively against all PubMed abstracts cited in PharmGKB. It may be possible to improve the system performance by incorporating using statistical machine learning approaches. This study also helped us gain insights into the barriers towards automated event extraction from text for pathway curation.
More Related Videos
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Biopharmaceutics and Pharmacokinetics: Overview
Pharmacogenetics and Pharmacogenomics: Overview
Drug Discovery: Overview
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

